{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:41:46Z","timestamp":1790624506936,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.resinv.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T08:37:43Z","timestamp":1563439063000},"page":"472-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7365-4927","authenticated-orcid":false,"given":"Nobuhiro","family":"Kanaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tadokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoya","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1097\/JTO.0000000000000673","volume":"10","author":"Eberhardt","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s12032-018-1182-8","article-title":"Impact of number versus location of metastases on survival in stage IV M1b non-small cell lung cancer","volume":"35","author":"Gibson","year":"2018","journal-title":"Med Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jtho.2016.11.2216","article-title":"Prognostic impact of newly proposed M descriptors in TNM classification of non-small cell lung cancer","volume":"12","author":"Shin","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"685","DOI":"10.21037\/jtd.2017.03.106","article-title":"Prognostic impact of M descriptors of the 8th edition of TNM classification of lung cancer","volume":"9","author":"Dias","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.resinv.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.2147\/TCRM.S164700","article-title":"Clinical features of patients with lung cancer accompanied by thromboembolism or disseminated intravascular coagulation","volume":"14","author":"Kanaji","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.resinv.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib7","first-page":"1907","article-title":"site of metastases as prognostic factors in unselected population of stage IV non-small cell lung cancer","volume":"19","author":"Ashour Badawy","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.resinv.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.lungcan.2015.02.012","article-title":"Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib","volume":"88","author":"Wu","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4103\/atm.ATM_385_17","article-title":"The pattern of bone involvement, management, and outcomes in patients with nonsmall cell lung cancer: A retrospective study","volume":"13","author":"Jazieh","year":"2018","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.resinv.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.21037\/jtd.2017.06.117","article-title":"Prognostic significance of sites of extrathoracic metastasis in patients with non-small cell lung cancer","volume":"9","author":"Bates","year":"2017","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.resinv.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2217\/fon-2017-0706","article-title":"The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: A large population-based study","volume":"14","author":"Cai","year":"2018","journal-title":"Future Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib12","article-title":"Skeletal muscle metastasis: An uncommon finding in lung cancer","author":"de Vega S\u00e1nchez","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resinv.2019.06.004_bib13","first-page":"1908","article-title":"Soft tissue metastases in lung cancer: A review of the literature","volume":"16","author":"Perisano","year":"2012","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.resinv.2019.06.004_bib14","first-page":"241","article-title":"Haematogenous muscular metastasis of non-small cell lung cancer in F-18 fluorodeoxyglucose positron emission tomography\/computed tomography","volume":"19","author":"Savas","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"key":"10.1016\/j.resinv.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ijc.26031","article-title":"The seed and soil hypothesis revisited--The role of tumor-stroma interactions in metastasis to different organs","volume":"128","author":"Langley","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF01753809","article-title":"Biomechanical destruction of cancer cells in skeletal muscle: A rate-regulator for hematogenous metastasis","volume":"7","author":"Weiss","year":"1989","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.resinv.2019.06.004_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2010.12.004","article-title":"The biology of cancer metastasis","volume":"21","author":"Fidler","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.resinv.2019.06.004_bib18","first-page":"98","article-title":"The distribution of secondary growths in cancer of the breast. 1889","volume":"8","author":"Paget","year":"1989","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.resinv.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JTO.0b013e3182398e69","article-title":"Hepatocyte growth factor induces resistance to anti-epidermal growth factor receptor antibody in lung cancer","volume":"7","author":"Yamada","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12931-017-0604-z","article-title":"Hepatocyte growth factor produced in lung fibroblasts enhances non-small cell lung cancer cell survival and tumor progression","volume":"18","author":"Kanaji","year":"2017","journal-title":"Respir Res"},{"key":"10.1016\/j.resinv.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0306-9877(80)90079-1","article-title":"Possible reasons for the high resistance of muscle to cancer","volume":"6","author":"Seely","year":"1980","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.resinv.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bjs.1800661007","article-title":"A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy","volume":"66","author":"Thomas","year":"1979","journal-title":"Br J Surg"},{"key":"10.1016\/j.resinv.2019.06.004_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/1097-0142(197501)35:1<15::AID-CNCR2820350104>3.0.CO;2-W","article-title":"Concepts for systemic treatment of micrometastases","volume":"35","author":"Schabel","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib24","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3109\/01902148.2016.1172370","article-title":"Confluence-dependent resistance to cisplatin in lung cancer cells is regulated by transforming growth factor-beta","volume":"42","author":"Yokokura","year":"2016","journal-title":"Exp Lung Res"},{"key":"10.1016\/j.resinv.2019.06.004_bib25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s12032-012-0352-3","article-title":"Preoperative lymphocyte count is a favorable prognostic factor of disease-free survival in non-small-cell lung cancer","volume":"30","author":"Zhang","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2217\/fon-2018-0667","article-title":"Neutrophil-to-lymphocyte ratio is superior to platelet-to-lymphocyte ratio as a prognostic predictor in advanced non-small-cell lung cancer treated with first-line platinum-based chemotherapy","volume":"15","author":"Guo","year":"2019","journal-title":"Future Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5301\/tj.5000632","article-title":"Significance of neutrophil-to-lymphocyte ratio in Western advanced EGFR-mutated non-small cell lung cancer receiving a targeted therapy","volume":"103","author":"Meriggi","year":"2017","journal-title":"Tumori"},{"key":"10.1016\/j.resinv.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2017.01.013","article-title":"Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer","volume":"106","author":"Bagley","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.lungcan.2017.07.024","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab","volume":"111","author":"Diem","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5306\/wjco.v5.i3.197","article-title":"Paraneoplastic syndromes associated with lung cancer","volume":"5","author":"Kanaji","year":"2014","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.resinv.2019.06.004_bib31","doi-asserted-by":"crossref","first-page":"39721","DOI":"10.1038\/srep39721","article-title":"KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: Poor prognosis in patients with KRAS mutation and bone metastasis","volume":"7","author":"Lohinai","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2019.06.004_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lungcan.2018.11.004","article-title":"New insights into the impact of primary lung adenocarcinoma location on metastatic sites and sequence: A multicenter cohort study","volume":"126","author":"Klikovits","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib33","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002324","article-title":"Distinct characteristics of small cell lung cancer correlate with central or peripheral origin: Subtyping based on location and expression of transcription factor TTF-1","volume":"94","author":"Miyauchi","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.resinv.2019.06.004_bib34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.lungcan.2017.03.013","article-title":"Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease","volume":"108","author":"Kanaji","year":"2017","journal-title":"Lung Cancer"},{"key":"10.1016\/j.resinv.2019.06.004_bib35","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1007\/s00432-016-2199-z","article-title":"Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival","volume":"142","author":"Kanaji","year":"2016","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534519300905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534519300905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T13:35:20Z","timestamp":1566999320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534519300905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2212534519300905"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2019.06.004","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of specific metastatic organs with the prognosis and chemotherapeutic response in patients with advanced lung cancer","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}